FLT3LG and neoplasm: Flt3L-secreting T cells expanded intratumoral cDC1s and increased host DC and T cell activation when combined with immune agonists poly (I:C) and agonistic anti-4-1BB, leading to enhanced tumor growth inhibition (170).